Submitted by Anonymous (not verified) on 22 July 2025 - 15:31
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised